The Patent Finder

Alteon, Inc.

Also on record
Records under this name other than patents Alteon, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Back to Alteon, Inc.

PatentTitleStatus Expires Confidence
US RE38,330Preventing and reversing advanced glycosylation endproducts
Term ended
Ended no later than Jan 18, 2015 · From the USPTO record
Term endedEnded no later than Jan 18, 2015From the USPTO record
US RE39,138Monoclonal antibody specific for advanced glycosylation endproducts in biological samples
Term ended
Term ended Dec 30, 2014 · From the USPTO record
Term endedTerm ended Dec 30, 2014From the USPTO record
US 7,026,342Method for treating fibrotic diseases or other indications utilizing thiazole, oxazole and imidazole compounds
Lapsed on the fee record
Ended Apr 11, 2014 · From the USPTO record
Lapsed on the fee recordEnded Apr 11, 2014From the USPTO record
US 6,960,605Thiazole, imidazole and oxazole compounds and treatments of disorders associated with protein aging
Lapsed on the fee record
Ended Nov 1, 2013 · From the USPTO record
Lapsed on the fee recordEnded Nov 1, 2013From the USPTO record
US 7,511,036Dihydrothiazine prodrugs of thiazolium agents
Formerly held
Lapsed on the fee record
Ended Mar 31, 2013 · From the USPTO record
Lapsed on the fee recordEnded Mar 31, 2013From the USPTO record
US 7,432,254Method for treating glaucoma IC
Formerly held
Lapsed on the fee record
Ended Oct 7, 2012 · From the USPTO record
Lapsed on the fee recordEnded Oct 7, 2012From the USPTO record
US 6,770,663Method for treating fibrotic diseases or other indications utilizing thiazole, oxazole and imidazole compounds
Lapsed on the fee record
Ended Aug 3, 2012 · From the USPTO record
Lapsed on the fee recordEnded Aug 3, 2012From the USPTO record
US 6,060,470Triazine compounds and methods of use therefor
Lapsed on the fee record
Ended May 9, 2012 · From the USPTO record
Lapsed on the fee recordEnded May 9, 2012From the USPTO record
US 6,713,498Method for treating glaucoma VI
Lapsed on the fee record
Ended Mar 30, 2012 · From the USPTO record
Lapsed on the fee recordEnded Mar 30, 2012From the USPTO record
US 6,025,401Method and agents for inhibiting protein aging
Lapsed on the fee record
Ended Feb 15, 2012 · From the USPTO record
Lapsed on the fee recordEnded Feb 15, 2012From the USPTO record
10 of 78 patents shown.
Pro members see all 78.
Pro members: see all 78 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited